Analystreport

Adamas Pharmaceuticals Inc (NASDAQ: ADMS) had its price target lowered by analysts at HC Wainwright from $40.00 to $30.00.

Adamas Pharmaceuticals, Inc.  (ADMS) 
Last adamas pharmaceuticals, inc. earnings: 2/25 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamaspharma.com/investors